Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial. Yapundich R, Applebee A, Bethoux F, Goldman MD, Hutton GJ, Mass M, Pardo G, Klingler M, Henney HR, Blight AR, et al. Int J MS Care. 2015 May-Jun; 17(3):138-45. PMID: 26052259. Abstract CommentRecommendBookmarkWatch